09.17.12
Recipharm Monts has received authorization from the French health authorities, ANSM, to fill biotech products, expanding its sterile product service offering. The Monts site comprises three filling lines, two large capacity lines for glass vials for injection and a third aseptic line that fills cartridges. Also, the company recently installed a new vials line at the site with multiple formats designed to handle smaller capacity orders. The first production line is designed to fill both clinical and small commercial batches, and will be available in mid 2013.
Michel Saudemon, general manager at Recipharm Monts, said, “We are delighted to have the opportunity to expand our sterile product manufacturing services with the authorized capability to fill biotech products.This regulatory approval, coming at a time when we have already set in place a program of strategic expansion at the Monts site with the installation of a new service line, will serve to increase the range of sterile product manufacturing services that we can offer to the markets.”
Michel Saudemon, general manager at Recipharm Monts, said, “We are delighted to have the opportunity to expand our sterile product manufacturing services with the authorized capability to fill biotech products.This regulatory approval, coming at a time when we have already set in place a program of strategic expansion at the Monts site with the installation of a new service line, will serve to increase the range of sterile product manufacturing services that we can offer to the markets.”
